Long-term oral administration of the NMDA receptor antagonist memantine extends life span in spinocerebellar ataxia type 1 knock-in mice

Neuroscience Letters
Akira IizukaHirokazu Hirai

Abstract

Spinocerebellar ataxia type 1 (SCA1) is a progressive neurodegenerative disease caused by extension of a CAG repeat in the Sca1gene. Although the mechanisms underlying the symptoms of SCA1 have not been determined, aberrant neuronal activation potentially contributes to the neuronal cell death characteristic of the disease. Here we examined the potential involvement of extrasynaptic N-methyl-d-aspartate receptor (NMDAR) activation in the pathogenesis of SCA1 by administering memantine, a low-affinity noncompetitive NMDAR antagonist, in SCA1 knock-in (KI) mice. In KI mice, the exon in the ataxin 1 gene is replaced with abnormally expanded 154CAG repeats. Memantine was administered orally to the SCA1 KI mice from 4 weeks of age until death. The treatment significantly attenuated body-weight loss and prolonged the life span of SCA1 KI mice. Furthermore, memantine significantly suppressed the loss of Purkinje cells in the cerebellum and motor neurons in the dorsal motor nucleus of the vagus, which are critical for motor function and parasympathetic function, respectively. These findings support the contribution of aberrant activation of extrasynaptic NMDARs to neuronal cell death in SCA1 KI mice and suggest that memantine may also ...Continue Reading

References

Mar 16, 2000·The American Journal of Medicine·P J Hornby, T P Abrahams
Mar 10, 2001·Respiration Physiology·D Jordan
Aug 12, 2003·Cell Calcium·Mark Arundine, Michael Tymianski
Sep 24, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yukihiro TakayasuSeiji Ozawa
Sep 29, 2007·The Journal of Physiology·Massimiliano RenziStuart G Cull-Candy
Oct 5, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Claire PiochonCarole Levenes
Dec 29, 2010·Frontiers in Neurology·Alice E McGovern, Stuart B Mazzone
Jun 7, 2011·Neuropharmacology·Pervin K IseriNurbay Ates
Aug 19, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Raphael HourezSerge N Schiffmann
Feb 9, 2012·Neuropathology and Applied Neurobiology·U RübT Deller
Jun 5, 2012·Experimental Physiology·Bashair M Mussa, Anthony J M Verberne

❮ Previous
Next ❯

Citations

Aug 30, 2016·Frontiers in Molecular Neuroscience·Jacob L WagnerNicholas M Boulis
Aug 11, 2017·Movement Disorders Clinical Practice·Alhassane DialloSophie Tezenas du Montcel
Sep 14, 2018·Frontiers in Molecular Neuroscience·Md JakariaDong-Kug Choi
Apr 18, 2020·Frontiers in Neuroscience·Francesca BindaSmita Saxena
Aug 9, 2020·Frontiers in Neuroscience·Katherine J RobinsonAngela S Laird

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.